# Mapping the research landscape of minor cannabinoids: a bibliometric analysis of research trends and hotspots

**Authors:** Hanane Abbou, Lahcen Belyamani, Rachid Eljaoudi

PMC · DOI: 10.1186/s42238-026-00402-2 · Journal of Cannabis Research · 2026-02-10

## TL;DR

This paper maps the growing research on minor cannabinoids like CBG and CBN, showing trends in scientific interest and collaboration since 2017.

## Contribution

The study provides a comprehensive bibliometric analysis of minor cannabinoid research, revealing thematic shifts and global collaboration patterns.

## Key findings

- Publication activity on minor cannabinoids grew exponentially starting in 2017, peaking in 2024.
- The U.S., Italy, and Canada led research, with key journals including Molecules and Cannabis and Cannabinoid Research.
- Recent research trends show a shift toward computational methods and molecular targeting of CBG and CBGA.

## Abstract

Minor cannabinoids, including cannabigerol (CBG), cannabinol (CBN), and cannabichromene (CBC), are gaining scientific attention for their distinct therapeutic potential beyond THC and CBD. Despite this growing interest, research on these compounds remains fragmented and underrepresented in the literature. This study aims to map the global research landscape of minor cannabinoids through bibliometric mapping analyses, identifying key trends, collaboration patterns, and emerging thematic areas.

A structured database search of the Scopus, PubMed, and WOS databases identified 1516 eligible articles published between 1969 and 2024. An inclusive search strategy was employed to capture minor cannabinoid research as it is embedded within the broader cannabinoid literature, ensuring that studies co-analyzing major and minor cannabinoids were not overlooked. Bibliometric analysis was conducted using the Biblioshiny tool to assess publication trends, journal impact, geographic distribution, and author collaboration networks.

Publication activity showed exponential growth starting in 2017, reaching a peak in 2024. The United States, Italy, and Canada led global contributions, with widespread international collaboration. Core publishing venues included Molecules, The Journal of Analytical Toxicology, the British Journal of Pharmacology, and Cannabis and Cannabinoid Research. Keyword co-occurrence analysis revealed three major thematic clusters. A sharp thematic shift has been observed since 2015, highlighting the rise of “CBG”, “CBGA” and “molecular docking”. This evolution marks a convergence of traditional pharmacology with molecular targeting and bioinformatics, signaling a transition toward computational and receptor-targeted research.

Minor cannabinoid research is expanding rapidly, with strong interdisciplinary foundations and growing global collaboration. This study provides a comprehensive overview of the field’s evolution and highlights underexplored areas ripe for future investigation.

The online version contains supplementary material available at 10.1186/s42238-026-00402-2.

## Linked entities

- **Chemicals:** cannabigerol (CBG) (PubChem CID 5315659), cannabinol (CBN) (PubChem CID 2543), cannabichromene (CBC) (PubChem CID 30219), CBGA (PubChem CID 6449999)

## Full-text entities

- **Chemicals:** cannabinoids (MESH:D002186)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12990395/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12990395/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12990395/full.md

---
Source: https://tomesphere.com/paper/PMC12990395